SOBRsafe Reports 136% Revenue Growth in Q3 2025 Driven by Alcohol Detection Technology Adoption
TL;DR
SOBRsafe's Q3 2025 revenue surged 136.1% with SOBRsure GEN 2 driving over 80% of sales, offering investors strong growth potential in alcohol detection technology.
SOBRsafe sold 277 devices, increased website traffic 266%, refined marketing to boost conversions, and grew annual recurring software revenue to $152.2 thousand up 60.5%.
SOBRsafe's touch-based alcohol detection provides dignified, passive screening that empowers recovery and builds trust through non-invasive technology for behavioral health and consumer markets.
SOBRsafe's technology detects alcohol through skin contact without breath, blood or urine samples, using advanced transdermal sensors for real-time monitoring.
Found this article helpful?
Share it with your network and spread the knowledge!

SOBRsafe Inc. reported significant financial momentum in the third quarter of 2025, with revenue increasing 136.1 percent year over year, driven primarily by accelerating adoption of the company's SOBRsure GEN 2 alcohol detection device. The technology accounted for more than 80 percent of quarterly revenue, demonstrating strong market acceptance of the company's touch-based approach to alcohol screening. The company's performance was bolstered by strategic commercial execution, including the sale of 277 devices during the quarter and a refined marketing strategy that boosted conversion rates. Website traffic surged 266 percent, reflecting growing interest in SOBRsafe's alternative to traditional breath, blood, or urine testing methods.
October marked the company's highest monthly sales performance, followed by its largest device order in November, indicating sustained demand momentum. Annual recurring software revenue reached $152.2 thousand, representing a 60.5 percent increase, while gross profit grew to $37.9 thousand. However, operating expenses rose as the company expanded commercial activities, and net loss widened to $2.2 million as SOBRsafe continues to invest in growth initiatives. The company maintained a cash position of $4.7 million to support ongoing commercialization efforts.
SOBRsafe's technology represents a significant advancement in alcohol detection, utilizing transdermal technology that detects alcohol presence through skin contact rather than requiring bodily fluid samples. This approach provides passive, real-time monitoring solutions for behavioral health, family law, and consumer markets. The company's backend data platform supports these applications while maintaining user dignity through non-invasive screening methods. Looking forward, SOBRsafe is advancing commercialization through expanded channel partnerships and continued investment in product development and software capabilities.
The company's progress in Q3 2025 suggests growing market recognition of the need for more dignified alcohol monitoring solutions. Additional information about the company's technology and business developments is available through its corporate communications at https://ibn.fm/SOBR. The financial results indicate that SOBRsafe's touch-based alcohol detection approach is gaining traction in markets traditionally dominated by more invasive testing methods, potentially signaling a shift toward more humane monitoring technologies across multiple sectors.
Curated from InvestorBrandNetwork (IBN)

